Concepedia

Jothi Anantharajan

JA

6

Publications

221

Citations

6

H-Index

2013

Active since

Affiliations

Experimental Drug Development Centre(Current)

University of Oulu

Jothi Anantharajan is an author at Experimental Drug Development Centre specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

2013–2021

6

Publications

6

Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors**

David Quach, Guanghui Tang, Jothi Anantharajan et al. · Angewandte Chemie International Edition · 2021 · 76 citations

Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells

Jothi Anantharajan, Hengbo Zhou, Lingdi Zhang et al. · Molecular Cancer Therapeutics · 2019 · 53 citations

The Structural Motifs for Substrate Binding and Dimerization of the α Subunit of Collagen Prolyl 4-Hydroxylase

Jothi Anantharajan, M. Kristian Koski, Petri Kursula et al. · Structure · 2013 · 36 citations · Full text

, , +9

Assembly of the elongated collagen prolyl 4-hydroxylase α2β2 heterotetramer around a central α2 dimer

M. Kristian Koski, Jothi Anantharajan, Petri Kursula et al. · Biochemical Journal · 2017 · 24 citations

Structural enzymology binding studies of the peptide‐substrate‐binding domain of human collagen prolyl 4‐hydroxylase (type‐II): High affinity peptides have a PxGP sequence motif

Abhinandan V. Murthy, Ramita Sulu, M. Kristian Koski et al. · Protein Science · 2018 · 19 citations · Full text

Rows per page

1–5 of 6